The Innovators Advancing Virtual Care Delivery across North America
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.
Technology has become the true innovator in healthcare, and with great technical and medical minds, the next generation of medical devices is here. Talking about their company’s innovations, Rob Kaul, CEO, and Dr. Sonny Kohli, Chief Medical Officer, of Cloud DX, joined I Don’t Care.
Kaul started the company over a decade ago with a focus on technology that was a new way to measure blood measure. Kaul and Dr. Kohli became acquainted over their shared vision. They ended up pursuing the XPRIZE for remote diagnostics and monitoring.
“It’s part of the Connected Health Platform and is FDA cleared and commercially available, helping those with COPD and congestive heart failure” – Robert Kaul
Dr. Kohli said, “The challenge was to create smartphone-based technology that could diagnose conditions and monitor vital signs in the cloud, which you could then apply analytics.”
They ended up winning with VITALITI, a wearable piece that can measure almost every vital sign. It’s currently in trials for FDA approval.
VITALTI, beyond the wearable, has a base station that can measure samples of fluid and diagnose and software that uses AI. “It can ask about symptoms, and we were looking at ways to diagnose pneumonia,” Kaul said.
That led them to a company in Boston that created technology to diagnose respiratory conditions based on coughing, which they licensed.
With the XPRIZE funding, the company began testing the cough technology to diagnose Tuberculosis, specifically in Mozambique, where it’s an epidemic. “It’s a major issue in the country, and detecting is very expensive, so this is a noninvasive way that can be a great screening tool,” Dr. Kohli explained.
The guests then went back to the blood pressure device, which is the Pulsewave. “It measures blood pressure differently,” Kaul noted. It has greater accuracy and delivers more data to identify arrhythmia or even if patients aren’t taking their medication.
“It’s part of the Connected Health Platform and is FDA cleared and commercially available, helping those with COPD and congestive heart failure,” Kaul said.
It’s the next horizon of remote patient monitoring and moving toward data-driven healthcare, which could improve patient outcomes.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
